newsfilter
← Latest News
ACCESS Newswire·

Biophytis Announces Next Regulatory Steps in Europe and the United States for its COVA Project

PARIS FRANCE and CAMBRIDGE, MA / ACCESSWIRE / August 16, 2023 / Biophytis SA , , a clinical-stage biotechnology company specialized in the development of therapeutics